Composition
- Active ingredients
- CLESROVIMAB-CFOR 105MG/0.7ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761432.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Enflonsia
- Active substance
- clesrovimab-cfor
- Route
- Solution
- Dosage form
- Injection
- Applicant
- Merck Sharp Dohme
- Status
- Prescription
- FDA approval
- 9 Jun 2025
- Application
- BLA761432-001